| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.44 | 0.002 |